Skip navigation
sponsored by 

Heartburn drug Nexium approved for children

FDA clears liquid and capsules for short-term use in kids ages one to 11

updated 11:31 a.m. ET Feb. 28, 2008

WASHINGTON - The Food and Drug Administration on Thursday approved AstraZeneca's Nexium to treat chronic heartburn in children.

The agency cleared two formulations of the drug — liquid and capsule — for short-term use in children one to 11 years old. According to the drug's new labeling, children should not take the drug for more than eight weeks.

FDA previously approved Nexium in the U.S. to treat heartburn in adults and adolescents.

Story continues below ↓
advertisement

Nexium was the world's second-best selling drug in 2006, according to health care research firm IMS Health.

The drug is part of a family of acid-reducing drugs known as proton pump inhibitors.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Sponsored links

Resource guide

Get Your 2008 Credit Score

Search Jobs

Find your next car

Find Your Dream Home

Find a business to start

$7 trades, no fee IRAs